Several specialized firms worldwide focus on the synthesis of complex drug APIs, notably Abacavir sulfate, Abarelix, and Abiraterone Mesylate. These substances present significant difficulties in process building due to their structural intricacy. The manufacturers of these APIs often employ sophisticated methods and adhere to strict compliance sta